Chromosome 7p11.2 (EGFR) variation influences glioma risk

Human Molecular Genetics

Volumn 20, Issue 14, 2011, Pages 2897-2904

  Sanson, Marc ^a,b   Hosking, Fay J ^c   Shete, Sanjay ^d   Zelenika, Diana ^e   Dobbins, Sara E ^c   Ma, Yussanne ^c   Enciso Mora, Victor ^c   Idbaih, Ahmed ^a,b   Delattre, Jean Yves ^a,b   Hoang Xuan, Khe ^a,b   Marie, Yannick ^a   Boisselier, Blandine ^a   Carpentier, Catherine ^a   Wang, Xiao Wei ^a   Di Stefano, Anna Luisa ^a   Labussière, Marianne ^a   Gousias, Konstantinos ^f   Schramm, Johannes ^f   Boland, Anne ^e   Lechner, Doris ^e   Gut, Ivo ^e   Armstrong, Georgina ^d   Liu, Yanhong ^d   Yu, Robert ^d   Lau, Ching ^g   Di Bernardo, Maria Chiara ^c   Robertson, Lindsay B ^c   Muir, Kenneth ^h   Hepworth, Sarah ⁱ   Swerdlow, Anthony ^c   Schoemaker, Minouk J ^c   Wichmann, H Erich ^j,k,l   Müller, Martina ^j,k,l   Schreiber, Stefan ^m,n   Franke, Andre ⁿ   Moebus, Susanne ^o   Eisele, Lewin ^o   Försti, Asta ^p   Hemminki, Kari ^p   Lathrop, Mark ^e,q   Bondy, Melissa ^d   Houlston, Richard S ^c   Simon, Matthias ^f   more..

^a SORBONNE UNIVERSITÉ   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e DIF   (France)

^f UNIVERSITY HOSPITAL BONN   (Germany)

^g BAYLOR COLLEGE OF MEDICINE   (United States)

^h UNIVERSITY OF WARWICK   (United Kingdom)

ⁱ UNIVERSITY OF LEEDS   (United Kingdom)

^j INSTITUTE OF EPIDEMIOLOGY   (Germany)

^k UNIVERSITY OF MUNICH   (Germany)

^l LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^m UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

ⁿ UNIVERSITY OF KIEL   (Germany)

^o UNIVERSITY HOSPITAL ESSEN   (Germany)

^p GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^q FONDATION JEAN DAUSSET CEPH   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ADULT; ARTICLE; AUTOSOME; CASE CONTROL STUDY; CHROMOSOME 7P; CHROMOSOME VARIANT; CONTROLLED STUDY; FEMALE; FRANCE; GENE DELETION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GERMANY; GLIOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 7; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENOME-WIDE ASSOCIATION STUDY; GLIOMA; HUMANS; ISOCITRATE DEHYDROGENASE; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, EPIDERMAL GROWTH FACTOR; RISK FACTORS;

EID: 79959793196     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddr192     Document Type: Article

References (28)

1. Linnebank, M., Semmler, A., Moskau, S., Smulders, Y., Blom, H. and Simon, M. (2008) The methylenetetrahydrofolate reductase (MTHFR) variant c.677C> T (A222V) influences overall survival of patients with glioblastoma multiforme. Neuro Oncol., 10, 548-552.
2. Sanson, M., Marie, Y., Paris, S., Idbaih, A., Laffaire, J., Ducray, F., El Hallani, S., Boisselier, B., Mokhtari, K., Hoang-Xuan, K. et al. (2009) Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas. J. Clin. Oncol., 27, 4150-4154.
3. Weller, M., Felsberg, J., Hartmann, C., Berger, H., Steinbach, J.P., Schramm, J., Westphal, M., Schackert, G., Simon, M., Tonn, J.C. et al. (2009) Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network. J. Clin. Oncol., 27, 5743-5750.
4. Bondy, M.L., Scheurer, M.E., Malmer, B., Barnholtz-Sloan, J.S., Davis, F.G., Il'yasova, D., Kruchko, C., McCarthy, B.J., Rajaraman, P., Schwartzbaum, J.A. et al. (2008) Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer, 113, 1953- 1968.
5. Hodgson, S. and Maher, E. (1999) A Practical Guide to Human Cancer Genetics, 2nd edn. Cambridge University Press, Cambridge, England, pp. 37-38.
6. Hemminki, K., Tretli, S., Sundquist, J., Johannesen, T.B. and Granstrom, C. (2009) Familial risks in nervous-system tumours: a histology-specific analysis from Sweden and Norway. Lancet Oncol., 10, 481-488.
7. Shete, S., Hosking, F.J., Robertson, L.B., Dobbins, S.E., Sanson, M., Malmer, B., Simon, M., Marie, Y., Boisselier, B., Delattre, J.Y. et al. (2009) Genome-wide association study identifies five susceptibility loci for glioma. Nat. Genet., 41, 899-904.
8. Wrensch, M., Jenkins, R.B., Chang, J.S., Yeh, R.F., Xiao, Y., Decker, P.A., Ballman, K.V., Berger, M., Buckner, J.C., Chang, S. et al. (2009) Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat. Genet., 41, 905-908.
9. Clayton, D.G., Walker, N.M., Smyth, D.J., Pask, R., Cooper, J.D., Maier, L.M., Smink, L.J., Lam, A.C., Ovington, N.R., Stevens, H.E. et al. (2005) Population structure, differential bias and genomic control in a large-scale, case-control association study. Nat. Genet., 37, 1243-1246.
10. Nobusawa, S., Watanabe, T., Kleihues, P. and Ohgaki, H. (2009) IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas. Clin. Cancer Res., 15, 6002-6007.
11. Ohgaki, H. and Kleihues, P. (2007) Genetic pathways to primary and secondary glioblastoma. Am. J. Pathol., 170, 1445-1453.
12. Schwartzbaum, J.A., Xiao, Y., Liu, Y., Tsavachidis, S., Berger, M.S., Bondy, M.L., Chang, J.S., Chang, S.M., Decker, P.A., Ding, B. et al. (2010) Inherited variation in immune genes and pathways and glioblastoma risk. Carcinogenesis, 31, 1770-1777.
13. Huang, P.H., Xu, A.M. and White, F.M. (2009) Oncogenic EGFR signaling networks in glioma. Sci. Signal, 2, re6.
14. The Cancer Genome Atlas Research Network. (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature, 455, 1061-1068.
15. Gan, H.K., Kaye, A.H. and Luwor, R.B. (2009) The EGFRvIII variant in glioblastoma multiforme. J. Clin. Neurosci., 16, 748-754.
16. Idbaih, A., Aimard, J., Boisselier, B., Marie, Y., Paris, S., Criniere, E., Carvalho Silva, R., Laigle-Donadey, F., Rousseau, A., Mokhtari, K. et al. (2009) Epidermal growth factor receptor extracellular domain mutations in primary glioblastoma. Neuropathol Appl Neurobiol., 35, 208-213.
17. Lee, J.C., Vivanco, I., Beroukhim, R., Huang, J.H., Feng, W.L., DeBiasi, R.M., Yoshimoto, K., King, J.C., Nghiemphu, P., Yuza, Y. et al. (2006) Epidermal growth factor receptor activation in glioblastoma through novel missense mutations in the extracellular domain. PLoS Med., 3, e485.
18. Simon, M., Hosking, F.J., Marie, Y., Gousias, K., Boisselier, B., Carpentier, C., Schramm, J., Mokhtari, K., Hoang-Xuan, K., Idbaih, A. et al. (2010) Genetic risk profiles identify different molecular etiologies for glioma. Clin. Cancer Res., 16, 5252-5259.
19. Cardis, E., Richardson, L., Deltour, I., Armstrong, B., Feychting, M., Johansen, C., Kilkenny, M., McKinney, P., Modan, B., Sadetzki, S. et al. (2007) The INTERPHONE study: design, epidemiological methods, and description of the study population. Eur. J. Epidemiol., 22, 647-664.
20. Hunter, D.J., Kraft, P., Jacobs, K.B., Cox, D.G., Yeager, M., Hankinson, S.E., Wacholder, S., Wang, Z., Welch, R., Hutchinson, A. et al. (2007) Agenome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat. Genet., 39, 870-874.
21. Yeager, M., Orr, N., Hayes, R.B., Jacobs, K.B., Kraft, P., Wacholder, S., Minichiello, M.J., Fearnhead, P., Yu, K., Chatterjee, N. et al. (2007) Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat. Genet., 39, 645-649.
22. Hercberg, S., Galan, P., Preziosi, P., Bertrais, S., Mennen, L., Malvy, D., Roussel, A.M., Favier, A. and Briancon, S. (2004) The SU.VI.MAX study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch. Intern. Med., 164, 2335-2342.
23. Holle, R., Happich, M., Lowel, H. and Wichmann, H.E. (2005) KORA-a research platform for population based health research. Gesundheitswesen, 67(Suppl. 1), S19-S25.
24. Wichmann, H.E., Gieger, C. and Illig, T. (2005) KORA-gen-resource for population genetics, controls and a broad spectrum of disease phenotypes. Gesundheitswesen, 67(Suppl. 1), S26-S30.
25. Krawczak, M., Nikolaus, S., von Eberstein, H., Croucher, P.J., El Mokhtari, N.E. and Schreiber, S. (2006) PopGen: population-based recruitment of patients and controls for the analysis of complex genotype-phenotype relationships. Community Genet., 9, 55-61.
26. Schmermund, A., Mohlenkamp, S., Stang, A., Gronemeyer, D., Seibel, R., Hirche, H., Mann, K., Siffert, W., Lauterbach, K., Siegrist, J. et al. (2002) Assessment of clinically silent atherosclerotic disease and established and novel risk factors for predicting myocardial infarction and cardiac death in healthy middle-aged subjects: rationale and design of the Heinz Nixdorf RECALL Study. Risk Factors, Evaluation of Coronary Calcium and Lifestyle. Am. Heart J., 144, 212-218.
27. Idbaih, A., Marie, Y., Lucchesi, C., Pierron, G., Manie, E., Raynal, V., Mosseri, V., Hoang-Xuan, K., Kujas, M., Brito, I. et al. (2008) BAC array CGH distinguishes mutually exclusive alterations that define clinicogenetic subtypes of gliomas. Int. J. Cancer, 122, 1778-1786.
28. Price, A.L., Patterson, N.J., Plenge, R.M., Weinblatt, M.E., Shadick, N.A. and Reich, D. (2006) Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet., 38, 904-909.